Emmes acquires vaxtrials

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced the acquisition of VaxTRIALS. 

Discover more


VaxTRIALS, an Emmes Company!


how do we make it possible?

Our motivation is the opportunity to contribute to the eradication of preventable diseases by reducing the time to market. As a key player in the region, we are at the forefront of vaccines clinical trials with innovative solutions and a high level of quality to achieve the expectations of our clients through the services we provide.   
Comprehensive management of vaccines clinical trials
We guide our clients through the main challenges of running clinical trials in Latin America.

External project support to investigational sites (EPS)
We provide support to clinical investigator sites in their development, as well as decision-making processes to improve their infrastructure and procedures.  
Expertise as a regional leader in vaccine research
Through our regional presence and local knowledge, we are a key partner in ensuring outstanding outcomes in vaccines clinical trials in Latin America.   

why vaxtrials?

Latin America has become one of the top emerging regions for clinical trials due to its diverse and large patient population, as well as its highly qualified professionals for conducting clinical research. Therefore, we provide turnkey vaccine trial services in the region.

Discover more

Our impact in numbers



Years in business




Recruited subjects


Completed visits


Recruited subjects per day


Vaccine licensed thanks to our contributions
By harnessing our local knowledge and experience in Latin America, we improve the quality of vaccine clinical research. As an outcome we have contributed to 6 vaccine licensures (Covid-19, Herpes Zoster, Polio, Meningitis, Dengue) running studies in 10 Latin-American countries.


We would like to make it possible with you too and become your partner in clinical research with our innovative solutions to contribute to a better world together.